Global Opioid Induced Constipation Drugs Market Data Survey Report 2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Ironwood Pharmaceuticals Inc
  • 3.1.2 Company Information
  • 3.1.2 Product Specifications
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.2 Daiichi Sankyo Co Ltd
  • 3.2.1 Company Information
  • 3.2.2 Product Specifications
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.3 Pfizer
  • 3.3.1 Company Information
  • 3.3.2 Product Specifications
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.4 Progenics Pharmaceuticals Inc
  • 3.4.1 Company Information
  • 3.4.2 Product Specifications
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.5 Shionogi & Co., Ltd
  • 3.5.1 Company Information
  • 3.5.2 Product Specifications
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.6 Allergan Plc
  • 3.6.1 Company Information
  • 3.6.2 Product Specifications
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Allergan Plc
  • 3.7.1 Company Information
  • 3.7.2 Product Specifications
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 Purdue Pharma
  • 3.8.1 Company Information
  • 3.8.2 Product Specifications
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 S.L.A. Pharma AG
  • 3.9.1 Company Information
  • 3.9.2 Product Specifications
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 Mundipharma International Limited
  • 3.10.1 Company Information
  • 3.10.2 Product Specifications
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.11 Ono Pharmaceutical Co., Ltd
• 3.12 Takeda Pharmaceutical Company Limited
• 3.13 Theravance Biopharma Inc
• 3.14 Valeant Pharmaceuticals International
• 3.15 Cosmo Pharmaceuticals SA
• 3.16 Daewoong Pharmaceutical
• 3.17 C.B. Fleet Company
• 3.18 Sucampo Pharmaceuticals

4 Major Application

• 4.1 Hospital Pharmacies
  • 4.1.1 Overview
  • 4.1.2 Hospital Pharmacies Market Size and Forecast
• 4.2 Retail Pharmacies
  • 4.2.1 Overview
  • 4.2.2 Retail Pharmacies Market Size and Forecast
• 4.3 Online Pharmacies
  • 4.3.1 Overview
  • 4.3.2 Online Pharmacies Market Size and Forecast

5 Market by Type

• 5.1 Lubiprostone
  • 5.1.1 Overview
  • 5.1.2 Lubiprostone Market Size and Forecast
• 5.2 Methyl Naltrexone Bromide
  • 5.2.1 Overview
  • 5.2.2 Methyl Naltrexone Bromide Market Size and Forecast
• 5.3 Naldemedine
  • 5.3.1 Overview
  • 5.3.2 Naldemedine Market Size and Forecast
• 5.4 Alvimopan
  • 5.4.1 Overview
  • 5.4.2 Alvimopan Market Size and Forecast
• 5.5 Others
  • 5.5.1 Overview
  • 5.5.2 Others Market Size and Forecast
• 5.6 Others
  • 5.6.1 Overview
  • 5.6.2 Others Market Size and Forecast

6 Conclusion